PDS Biotechnology Post-ASCO Conference Call Tomorrow, June 6, at 8 a.m. ET
FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted…